MDA-9 and uses thereof

作者: Mark Williamson

DOI:

关键词:

摘要: Increased expression of MDA-9 is associated with drug resistance certain cells (e.g., cancer cells). The invention provides methods for identifying resistant by measuring the or activity MDA-9, modulators resistance, and modulating MDA-9.

参考文章(9)
William C. Broaddus, Sujit S. Prabhu, Susanna Wu-Pong, George T. Gillies, Helen Fillmore, Strategies for the design and delivery of antisense oligonucleotides in central nervous system. Methods in Enzymology. ,vol. 314, pp. 121- 135 ,(2000) , 10.1016/S0076-6879(99)14099-0
Adrian L. Harris, Daniel Hochhauser, Mechanisms of Multidrug Resistance in Cancer Treatment Acta Oncologica. ,vol. 31, pp. 205- 213 ,(1992) , 10.3109/02841869209088904
S. M. Simon, M. Schindler, Cell biological mechanisms of multidrug resistance in tumors Proceedings of the National Academy of Sciences of the United States of America. ,vol. 91, pp. 3497- 3504 ,(1994) , 10.1073/PNAS.91.9.3497
J. J. Grootjans, P. Zimmermann, G. Reekmans, A. Smets, G. Degeest, J. Durr, G. David, Syntenin, a PDZ protein that binds syndecan cytoplasmic domains Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 13683- 13688 ,(1997) , 10.1073/PNAS.94.25.13683
Pascale Zimmermann, Guido David, Jan Grootjans, Syndecan interacting proteins and the use thereof ,(1998)